If you are visually impaired or blind, you can visit the PDF version by Pressing CONTROL + ALT + 4
<br /> +<br /> COMMUNITY PARAMEDICINE<br /> PROGRAMS<br /> An innovation worthy of further study<br /> 14 & 21<br /> How to pay for<br /> national pharmacare<br /> 27<br /> Powassan<br /> encephalitis<br /> 48<br /> FEBRUARY 2019<br /> Publications Mail Agreement no. 41387051; USPS #0762-530.<br /> NOW AVAILABLE: 2.5 mg tablets<br /> Consider Xarelto®<br /> for your Patients<br /> with CAD<br /> Xarelto® - the 1st and only NOAC indicated in combination with ASA to<br /> prevent myocardial infarction, stroke and cardiovascular death, in patients with<br /> coronary artery disease (CAD) with or without peripheral artery disease (PAD)1†<br /> PrXarelto® (rivaroxaban) film-coated tablet (2.5 mg), in combination with 75 mg – 100 mg acetylsalicylic acid (ASA) is<br /> indicated for the prevention of stroke, myocardial infarction and cardiovascular death, and for the p<a title="CMAJ February 2019 page 1" href="http://viewer.zmags.com/publication/dd45c039?page=1"> + COMMUNITY PARAMEDICINE PROGRAMS An innovat</a> <a title="CMAJ February 2019 page 2" href="http://viewer.zmags.com/publication/dd45c039?page=2"> NOW AVAILABLE: 2.5 mg tablets Con</a> <a title="CMAJ February 2019 page 3" href="http://viewer.zmags.com/publication/dd45c039?page=3"> 6 EDITORIAL 6 A national electronic health</a> <a title="CMAJ February 2019 page 4" href="http://viewer.zmags.com/publication/dd45c039?page=4"> 55 4858 The medical profession’s role </a> <a title="CMAJ February 2019 page 5" href="http://viewer.zmags.com/publication/dd45c039?page=5"> Consider LIXIANA® Indicated for the prevention o</a> <a title="CMAJ February 2019 page 6" href="http://viewer.zmags.com/publication/dd45c039?page=6"> FEBRUARY 2019 FangXiaNuo/iStock COVER In this s</a> <a title="CMAJ February 2019 page 7" href="http://viewer.zmags.com/publication/dd45c039?page=7"> BETTER TOGE+HER #1 Dermatologist Recommended </a> <a title="CMAJ February 2019 page 8" href="http://viewer.zmags.com/publication/dd45c039?page=8"> + EDITORIAL HEALTH SERVICES A NATIONAL ELECT</a> <a title="CMAJ February 2019 page 9" href="http://viewer.zmags.com/publication/dd45c039?page=9"> Affairs implemented a national elec- tronic healt</a> <a title="CMAJ February 2019 page 10" href="http://viewer.zmags.com/publication/dd45c039?page=10"> + LETTERS CONSIDERING CONTEXT WITHIN #METOO AND T</a> <a title="CMAJ February 2019 page 11" href="http://viewer.zmags.com/publication/dd45c039?page=11"> To gain maximal effect, we must avoid compartment</a> <a title="CMAJ February 2019 page 12" href="http://viewer.zmags.com/publication/dd45c039?page=12"> + LETTERS 3. Orr SK, Dachner N, Frank L, et </a> <a title="CMAJ February 2019 page 13" href="http://viewer.zmags.com/publication/dd45c039?page=13"> + COMMENTARY HEALTH SERVICES A CALL TO MAND</a> <a title="CMAJ February 2019 page 14" href="http://viewer.zmags.com/publication/dd45c039?page=14"> + COMMENTARY to patients so that all this inform</a> <a title="CMAJ February 2019 page 15" href="http://viewer.zmags.com/publication/dd45c039?page=15"> untapped potential of patient engagement is a tri</a> <a title="CMAJ February 2019 page 16" href="http://viewer.zmags.com/publication/dd45c039?page=16"> + COMMENTARY HEALTH SERVICES COMMUNITY PARAMED</a> <a title="CMAJ February 2019 page 17" href="http://viewer.zmags.com/publication/dd45c039?page=17"> assessment and management program is a unique exa</a> <a title="CMAJ February 2019 page 18" href="http://viewer.zmags.com/publication/dd45c039?page=18"> + COMMENTARY NONFASTING LIPID TESTING: THE NEW ST</a> <a title="CMAJ February 2019 page 19" href="http://viewer.zmags.com/publication/dd45c039?page=19"> 20%, at most, postprandially.4,5 Low­ density–lip</a> <a title="CMAJ February 2019 page 20" href="http://viewer.zmags.com/publication/dd45c039?page=20"> + COMMENTARY targeting a non­HDL cholesterol lev</a> <a title="CMAJ February 2019 page 21" href="http://viewer.zmags.com/publication/dd45c039?page=21"> + RESEARCH | VISUAL ABSTRACT VULNERABLE POPULAT</a> <a title="CMAJ February 2019 page 22" href="http://viewer.zmags.com/publication/dd45c039?page=22"> + RESEARCH | SYNOPSIS VULNERABLE POPULATIONS </a> <a title="CMAJ February 2019 page 23" href="http://viewer.zmags.com/publication/dd45c039?page=23"> + RESEARCH | SYNOPSIS VULNERABLE POPULATIONS</a> <a title="CMAJ February 2019 page 24" href="http://viewer.zmags.com/publication/dd45c039?page=24"> + RESEARCH | SYNOPSIS HEALTH SERVICES Patient, </a> <a title="CMAJ February 2019 page 25" href="http://viewer.zmags.com/publication/dd45c039?page=25"> + RESEARCH | SYNOPSIS Validation and refinement o</a> <a title="CMAJ February 2019 page 26" href="http://viewer.zmags.com/publication/dd45c039?page=26"> STRONGLY RECOMMENDED BY NACI The National </a> <a title="CMAJ February 2019 page 27" href="http://viewer.zmags.com/publication/dd45c039?page=27"> SHINGRIX demonstrated >90% efficacy against shing</a> <a title="CMAJ February 2019 page 28" href="http://viewer.zmags.com/publication/dd45c039?page=28"> OPEN WHAT’S NEW cmajopen.ca Risk of UTIs with so</a> <a title="CMAJ February 2019 page 29" href="http://viewer.zmags.com/publication/dd45c039?page=29"> + ANALYSIS HEALTH SERVICES HOW TO PAY FOR NA</a> <a title="CMAJ February 2019 page 30" href="http://viewer.zmags.com/publication/dd45c039?page=30"> + ANALYSIS What is the estimated cost of pharmac</a> <a title="CMAJ February 2019 page 31" href="http://viewer.zmags.com/publication/dd45c039?page=31"> What would be the net cost to the federal governm</a> <a title="CMAJ February 2019 page 32" href="http://viewer.zmags.com/publication/dd45c039?page=32"> + ANALYSIS appear to be a progressive and sym- b</a> <a title="CMAJ February 2019 page 33" href="http://viewer.zmags.com/publication/dd45c039?page=33"> corporate income tax rates and a 0.25 per- </a> <a title="CMAJ February 2019 page 34" href="http://viewer.zmags.com/publication/dd45c039?page=34"> + REVIEW CPD ADVERSE EVENTS ASSOCIATED WITH IMMUN</a> <a title="CMAJ February 2019 page 35" href="http://viewer.zmags.com/publication/dd45c039?page=35"> What are immune checkpoint inhibitors and how do </a> <a title="CMAJ February 2019 page 36" href="http://viewer.zmags.com/publication/dd45c039?page=36"> + REVIEW Table 1: Health Canada–approved indicati</a> <a title="CMAJ February 2019 page 37" href="http://viewer.zmags.com/publication/dd45c039?page=37"> REVIEW + Table 2: Rates of the more common immune</a> <a title="CMAJ February 2019 page 38" href="http://viewer.zmags.com/publication/dd45c039?page=38"> + REVIEW Assess symptoms and causeDeter</a> <a title="CMAJ February 2019 page 39" href="http://viewer.zmags.com/publication/dd45c039?page=39"> limited, evidence to support this. These patients</a> <a title="CMAJ February 2019 page 40" href="http://viewer.zmags.com/publication/dd45c039?page=40"> + REVIEW 9. Desforges P, Esfahani K, Bouganim</a> <a title="CMAJ February 2019 page 41" href="http://viewer.zmags.com/publication/dd45c039?page=41"> + PRACTICE | INNOVATIONS CPD Percutaneous left a</a> <a title="CMAJ February 2019 page 42" href="http://viewer.zmags.com/publication/dd45c039?page=42"> + PRACTICE What is percutaneous left atrial appe</a> <a title="CMAJ February 2019 page 43" href="http://viewer.zmags.com/publication/dd45c039?page=43"> How is it performed? Left atrial appendage closu</a> <a title="CMAJ February 2019 page 44" href="http://viewer.zmags.com/publication/dd45c039?page=44"> + PRACTICE annualized rates of 1.9% for stroke, </a> <a title="CMAJ February 2019 page 45" href="http://viewer.zmags.com/publication/dd45c039?page=45"> + PRACTICE | WHAT IS YOUR CALL? CPD A </a> <a title="CMAJ February 2019 page 46" href="http://viewer.zmags.com/publication/dd45c039?page=46"> + PRACTICE The correct answer is (d). The 2016 g</a> <a title="CMAJ February 2019 page 47" href="http://viewer.zmags.com/publication/dd45c039?page=47"> Box 1: Revised cardiac risk index criteria* and d</a> <a title="CMAJ February 2019 page 48" href="http://viewer.zmags.com/publication/dd45c039?page=48"> + PRACTICE Box 2: Troponin criteria for diagnosi</a> <a title="CMAJ February 2019 page 49" href="http://viewer.zmags.com/publication/dd45c039?page=49"> Management of patients at high risk in the periop</a> <a title="CMAJ February 2019 page 50" href="http://viewer.zmags.com/publication/dd45c039?page=50"> + PRACTICE | CASES CPD A CASE OF POWASSAN ENC</a> <a title="CMAJ February 2019 page 51" href="http://viewer.zmags.com/publication/dd45c039?page=51"> for Powassan virus and western equine encephaliti</a> <a title="CMAJ February 2019 page 52" href="http://viewer.zmags.com/publication/dd45c039?page=52"> + PRACTICE lower extremities, with improvement i</a> <a title="CMAJ February 2019 page 53" href="http://viewer.zmags.com/publication/dd45c039?page=53"> Treatment Treatment of Powassan encephalitis is s</a> <a title="CMAJ February 2019 page 54" href="http://viewer.zmags.com/publication/dd45c039?page=54"> + PRACTICE | FIVE THINGS TO KNOW ABOUT ... BUPREN</a> <a title="CMAJ February 2019 page 55" href="http://viewer.zmags.com/publication/dd45c039?page=55"> + PRACTICE | CLINICAL IMAGES MOYAMOYA DISEASE Ta</a> <a title="CMAJ February 2019 page 56" href="http://viewer.zmags.com/publication/dd45c039?page=56"> + PRACTICE attack, ischemic stroke, hemorrhage a</a> <a title="CMAJ February 2019 page 57" href="http://viewer.zmags.com/publication/dd45c039?page=57"> + NEWS AGEISM IN MEDICINE A PRESSING PROBLEM n</a> <a title="CMAJ February 2019 page 58" href="http://viewer.zmags.com/publication/dd45c039?page=58"> + NEWS training,” which noted that “the four- ye</a> <a title="CMAJ February 2019 page 59" href="http://viewer.zmags.com/publication/dd45c039?page=59"> Fewer family doctors want to provide comprehensiv</a> <a title="CMAJ February 2019 page 60" href="http://viewer.zmags.com/publication/dd45c039?page=60"> + NEWS GUN VIOLENCE IS AN EPIDEMIC AND “WE </a> <a title="CMAJ February 2019 page 61" href="http://viewer.zmags.com/publication/dd45c039?page=61"> Dr. Katherine Austin. “In Canada, we tend to comp</a> <a title="CMAJ February 2019 page 62" href="http://viewer.zmags.com/publication/dd45c039?page=62"> + NEWS CONCERNS ABOUT SURGICAL SKILLS SLIPPI</a> <a title="CMAJ February 2019 page 63" href="http://viewer.zmags.com/publication/dd45c039?page=63"> What has changed, in his view, is “the complexity</a> <a title="CMAJ February 2019 page 64" href="http://viewer.zmags.com/publication/dd45c039?page=64"> + HUMANITIES | ENCOUNTERS VULNERABLE POPULATIO</a> <a title="CMAJ February 2019 page 65" href="http://viewer.zmags.com/publication/dd45c039?page=65"> Lisa Boivin Cutting Away Culture: Severance from</a> <a title="CMAJ February 2019 page 66" href="http://viewer.zmags.com/publication/dd45c039?page=66"> + HUMANITIES | ENCOUNTERS THE MATHEMATICS OF CRO</a> <a title="CMAJ February 2019 page 67" href="http://viewer.zmags.com/publication/dd45c039?page=67"> + HUMANITIES | ENCOUNTERS MENTAL HEALTH DOCTOR</a> <a title="CMAJ February 2019 page 68" href="http://viewer.zmags.com/publication/dd45c039?page=68"> + DANS LE CMAJ ÉDITORIALSERVICES DE SANTÉ UN DO</a> <a title="CMAJ February 2019 page 69" href="http://viewer.zmags.com/publication/dd45c039?page=69"> une décision qui affectera leur pratique quotidie</a> <a title="CMAJ February 2019 page 70" href="http://viewer.zmags.com/publication/dd45c039?page=70"> + DANS LE CMAJ [pp], intervalle de confiance [IC</a> <a title="CMAJ February 2019 page 71" href="http://viewer.zmags.com/publication/dd45c039?page=71"> DANS LE CMAJ + RÉSUMÉ DE RECHERCHE SERVIC</a> <a title="CMAJ February 2019 page 72" href="http://viewer.zmags.com/publication/dd45c039?page=72"> + DANS LE CMAJ MÉTHODES : Nous avons procédé à d</a> <a title="CMAJ February 2019 page 73" href="http://viewer.zmags.com/publication/dd45c039?page=73"> + CAREER/CLASSIFIED ADVERTISING drcareers.ca CMAJ</a> <a title="CMAJ February 2019 page 74" href="http://viewer.zmags.com/publication/dd45c039?page=74"> INTENSIVE 1-DAY COURSE Spring 2019: April 15 Hilt</a> <a title="CMAJ February 2019 page 75" href="http://viewer.zmags.com/publication/dd45c039?page=75"> RURAL LOCUMS Fam</a> <a title="CMAJ February 2019 page 76" href="http://viewer.zmags.com/publication/dd45c039?page=76"> CLASSIFIED ADVERTISING ACADEMIC PALLIATIVE CARE </a> <a title="CMAJ February 2019 page 77" href="http://viewer.zmags.com/publication/dd45c039?page=77"> Applicants must be eligible for licence to practi</a> <a title="CMAJ February 2019 page 78" href="http://viewer.zmags.com/publication/dd45c039?page=78"> CLASSIFIED ADVERTISING PHYSICIAN - HOSPITALIST </a> <a title="CMAJ February 2019 page 79" href="http://viewer.zmags.com/publication/dd45c039?page=79"> POSITIONS VACANT PAIN PHYSICIAN: ON – Pain clin</a> <a title="CMAJ February 2019 page 80" href="http://viewer.zmags.com/publication/dd45c039?page=80"> CLASSIFIED ADVERTISING OTOLARYNGOLOGIST HEAD & N</a> <a title="CMAJ February 2019 page 81" href="http://viewer.zmags.com/publication/dd45c039?page=81"> POSITIONS VACANT PEDIATRICIAN </a> <a title="CMAJ February 2019 page 82" href="http://viewer.zmags.com/publication/dd45c039?page=82"> + CODA PATIENT SKETCHES TURNED ME INTO A DREAM</a> <a title="CMAJ February 2019 page 83" href="http://viewer.zmags.com/publication/dd45c039?page=83"> Available now The Power of Fucibet®: Fusidi</a> <a title="CMAJ February 2019 page 84" href="http://viewer.zmags.com/publication/dd45c039?page=84"> Advertisement The Clinical Case for Complementin</a>